Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. The company is headquartered in Alameda, California and currently employs 42 full-time employees. The company went IPO on 2014-12-05. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Follow-Up Questions
¿Quién es el CEO de Vivani Medical Inc?
Dr. Adam Mendelsohn es el Chief Executive Officer de Vivani Medical Inc, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción VANI?
El precio actual de VANI es de $1.53, ha increased un 1.99% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Vivani Medical Inc?
Vivani Medical Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Vivani Medical Inc?
La capitalización bursátil actual de Vivani Medical Inc es $90.9M
¿Es Vivani Medical Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 5 analistas han realizado calificaciones de análisis para Vivani Medical Inc, incluyendo 2 fuerte compra, 5 compra, 1 mantener, 0 venta, y 2 fuerte venta